Dec 15, 2020 / 07:20PM GMT
Unidentified Participant
Hello. We have Josh from Aytu BioScience. Aytu BioScience is a commercial stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. If our panelists can go offline, Josh, you have the floor.
Josh Disbrow - Aytu BioScience, Inc, - Chairman & CEO
Great. Thanks very much. Good afternoon, everyone. Good morning, if you're on the West Coast, and thanks for joining us for this presentation. I'll keep this relatively brief just because we are on a relatively constrained timeframe here, but excited to be with you here to share with you some relatively late breaking news with respect to Aytu.
As mentioned, Aytu BioScience is a specialty pharmaceutical company. We are a commercial stage company, and we're focused on acquiring and or licensing assets in both the prescription and the consumer health care markets. We've undergone a significant transformation over the
Aytu BioScience Inc at LD Micro Main Event Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot